SEI INVESTMENTS CO - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 155 filers reported holding ASCENDIS PHARMA A/S in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.7%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$37,122,652
+1.4%
396,440
-3.4%
0.07%
+4.7%
Q2 2023$36,626,714
-28.2%
410,384
-13.8%
0.06%
-32.6%
Q1 2023$51,038,950
-4.4%
476,021
+8.9%
0.10%
-20.2%
Q4 2022$53,401,449
+9.2%
437,251
-7.7%
0.12%
+9.2%
Q3 2022$48,895,000
+16.4%
473,519
+4.8%
0.11%
+19.8%
Q2 2022$42,001,000
-19.5%
451,801
+1.6%
0.09%
-13.3%
Q1 2022$52,170,000
-8.3%
444,559
+5.2%
0.10%
-1.9%
Q4 2021$56,865,000
-8.3%
422,691
+8.6%
0.11%
-17.7%
Q3 2021$62,039,000
+58.1%
389,223
+30.5%
0.13%
+49.4%
Q2 2021$39,247,000
+16.0%
298,321
+13.7%
0.09%
+2.4%
Q1 2021$33,830,000
-16.6%
262,392
+7.9%
0.08%
-19.0%
Q4 2020$40,551,000
+11.9%
243,102
+3.5%
0.10%0.0%
Q3 2020$36,229,000
+62.6%
234,774
+55.8%
0.10%
+52.2%
Q2 2020$22,281,000
+129.6%
150,652
+74.8%
0.07%
+91.7%
Q1 2020$9,705,000
+5.8%
86,186
+30.8%
0.04%
+33.3%
Q4 2019$9,169,000
+46.4%
65,908
+1.4%
0.03%
+68.8%
Q3 2019$6,262,000
+23.4%
65,009
+47.5%
0.02%
-5.9%
Q2 2019$5,075,000
+71.8%
44,071
+75.6%
0.02%
+70.0%
Q1 2019$2,954,00025,1000.01%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2020
NameSharesValueWeighting ↓
RA Capital Management 5,909,742$911,991,00016.68%
Vivo Capital, LLC 1,797,745$277,428,00016.03%
Sofinnova Investments, Inc. 1,109,874$171,276,00012.70%
Asymmetry Capital Management, L.P. 81,442$12,568,0008.08%
Ghost Tree Capital, LLC 130,000$20,062,0005.80%
Eversept Partners, LP 161,004$24,846,1375.52%
Eventide Asset Management 1,709,848$263,864,0005.16%
Avoro Capital Advisors LLC 1,800,000$277,776,0003.95%
BERYLSON CAPITAL PARTNERS, LLC 72,700$11,219,0003.93%
Spyglass Capital Management LLC 547,022$84,416,0003.90%
View complete list of ASCENDIS PHARMA A/S shareholders